Updated: May 19, 2026

Rahul D. Ballal

ELVNEnliven Therapeutics, Inc.SEC CIK: 0001805097
Estimated Net Worth
$3.23 Million70.5%vs Last Year
Last Updated: May 19, 2026 11:48 PM EST

Transaction Summary

Total Transactions27
Buy-Sell Ratio1.10
Buy Transactions11
Sell Transactions10

Transaction Volume

Total Volume$1.99M
Net Volume-$1.99M
Buy Volume$0
Sell Volume$1.99M

Trade Analysis

AVG Trade Size$73.56K
Largest Trade$688.19K
Most Active MonthFeb
Most Active Year2024

Trading Sentiment

OverallBearish
Recent TradeBuying
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading chart

Monthly Trading Pattern

Loading chart

Past Insider Trading and Trends

Rahul D. Ballal has an estimated net worth of $3.23 Million. This is based on reported shares across multiple companies, which include Enliven Therapeutics, Inc., and AGIOS PHARMACEUTICALS, INC..



2024 was Rahul D. Ballal's most active year for acquiring shares with 17 total transactions. Rahul D. Ballal's most active month to acquire stocks was the month of May. 2024 was Rahul D. Ballal's most active year for disposing of shares, totalling 26 transactions. Rahul D. Ballal's most active month to dispose stocks was the month of March. 2024 saw Rahul D. Ballal paying a total of $1,679,090.36 for 177,203 shares, this is the most they've acquired in one year. In 2024 Rahul D. Ballal cashed out on 240,530 shares for a total of $3,358,466.45, their largest year based on trade value.

Holdings & Transactions

Loading…
Loading…